ChemDiv Expands Collaboration for Ratutrelvir Development as a Leading COVID-19 Treatment ChemDiv has announced the extension of its collaboration on CMC services for Ratutrelvir, a promising COVID-19 therapeutic now in Phase 2 trials.

ChemDiv Expands Collaboration for Ratutrelvir Development as a Leading COVID-19 Treatment #USA #San_Diego #Traws_Pharma #Ratutrelvir #ChemDiv

ChemDiv's Enhanced Discovery Platform Advances EGFR Inhibitors for Lung Cancer Treatment ChemDiv unveils upgraded designs and synthesis for reversible pan-EGFR inhibitors targeting lung cancer, enhancing efficacy and safety.

ChemDiv's Enhanced Discovery Platform Advances EGFR Inhibitors for Lung Cancer Treatment #USA #San_Diego #Lung_Cancer #EGFR_inhibitors #ChemDiv

ChemDiv Strengthens Partnership with Clywedog After Barinthus Merger ChemDiv is set to continue its support for Clywedog Therapeutics, following Clywedog's merger with Barinthus Therapeutics, focusing on diabetes treatments.

ChemDiv Strengthens Partnership with Clywedog After Barinthus Merger #United_States #San_Diego #ChemDiv #Clywedog #Barinthus

ChemDiv and Mondego Bio Strengthen Partnership for Immuno-Oncology Advancements in PTPN2 Targeting ChemDiv has extended its partnership with Mondego Bio to enhance the development of innovative immuno-oncology therapies targeting PTPN2.

ChemDiv and Mondego Bio Strengthen Partnership for Immuno-Oncology Advancements in PTPN2 Targeting #USA #San_Diego #Mondego_Bio #ChemDiv #PTPN2

🥦This was the first open cabbage field day at IGZ last week: Insights into research on Brassica oleracea, from sustainable farming to nutrient diversity.
Discover more here:#SharpGreens #VEGAMIN #NEmGem #BioStripPlant #ChemDiv #GreenCycle

igzev.de/en/latest/news…